Back to User profile » Prof. Dr. Changcheng Zheng
Papers published by Prof. Dr. Changcheng Zheng:
Superior Efficacy and Deep Molecular Remission with Venetoclax Plus Hypomethylating Agent in Elderly Acute Myeloid Leukemia: A Real-World Comparative Cohort Study
Luo C, Jiang Y, Yan H, Sun K, Li W, Cao M, Zhu L, Hu X, Tong J, Zheng C
Clinical Pharmacology: Advances and Applications 2026, 18:596901
Published Date: 3 May 2026
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592550
Published Date: 24 April 2026
Development and Validation of a Novel Thrombosis Prediction Model for Adult Immune Thrombocytopenia (ITP-THROMBO)
Yan H, Hu X, Zhu L, Jiang Y, Luo C, Lv M, Wang Y, Tong J, Zheng C
Journal of Blood Medicine 2026, 17:570135
Published Date: 21 January 2026
Real-World Analysis of Clinical Characteristics, Treatment Outcomes, and the Novel Predictive Model for Patients with Thrombotic Thrombocytopenic Purpura (TTP) and TTP-Like Syndrome
Lv M, Hu X, Zhu L, Xu H, Chen E, Zhao N, Tong J, Zheng C
Vascular Health and Risk Management 2025, 21:153-165
Published Date: 24 March 2025
Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF
Liu D, Tong J, Chen E, Wang L, Xue L, Zhang X, Zhao N, Hu X, Zheng C
Blood and Lymphatic Cancer: Targets and Therapy 2024, 14:63-69
Published Date: 29 July 2024
Can COVID-19 Increase Platelet in Adult Immune Thrombocytopenia During the TPO-RA Administration? A Real-World Observational Study
Wang X, Zhu Y, Liu D, Zhu L, Tong J, Zheng C
Journal of Blood Medicine 2024, 15:217-225
Published Date: 7 May 2024
Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes
Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C
ImmunoTargets and Therapy 2023, 12:135-147
Published Date: 23 November 2023
Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study
Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Tang B, Liu H, Zhu W, Cai X, Liu X, Zhu X, Sun Z, Zheng C
Clinical Interventions in Aging 2022, 17:55-64
Published Date: 20 January 2022
Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia
Lin X, Xu A, Zhou L, Zhao N, Zhang X, Xu J, Feng S, Zheng C
International Journal of General Medicine 2021, 14:937-947
Published Date: 18 March 2021
Clinical Features and Short-Term Outcomes in COVID-19-Infected Patients with Cancer
Wang Y, Shan BJ, Shen XB, Zheng CC, Wang JQ, Li GL, Pan YY
Cancer Management and Research 2020, 12:12021-12028
Published Date: 23 November 2020
Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma
Zhou L, Zhang X, Feng S, Zhao N, Hu X, Huang L, Zheng C
OncoTargets and Therapy 2020, 13:237-241
Published Date: 9 January 2020
Impact Of ELN Risk Stratification, Induction Chemotherapy Regimens And Hematopoietic Stem Cell Transplantation On Outcomes In Hyperleukocytic Acute Myeloid Leukemia With Initial White Blood Cell Count More Than 100 × 109/L
Feng S, Zhou L, Zhang X, Tang B, Zhu X, Liu H, Sun Z, Zheng C
Cancer Management and Research 2019, 11:9495-9503
Published Date: 8 November 2019